The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000851369
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
27/06/2026
Date registered
Help: Date registered
13/07/2026
Date last updated
Help: Date last updated
13/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
13/07/2026
Type of registration
Help: Type of registration
Retrospectively registered

Titles & IDs
Public title
Does Length Matter? Impact of ureteric stent length on patient-reported stent symptoms – early findings from a prospective paired study at a single institution
Scientific title
Impact of fixed-length compared with multilength ureteric stents on patient-reported symptom burden following ureteroscopy for urinary stone disease: a prospective single-centre non-randomised comparative study.
Additional trial identifiers [1] 317721 0
N/A
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Ureteric calculi requiring ureteric stenting 342609 0
Condition category
Condition code
Renal and Urogenital 338764 338764 0 0
Other renal and urogenital disorders

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Allocation: Non-randomised

Intervention administered by Urology Registrar/Consultant - all relevant proceduralists asked to place multilength stents at first encounter and fixed length at second encounter for the duration of the study (June 30-Dec 31, 2025) and this is confirmed on the operation report

Duration of procedure: 15-30mins
Frequency of procedure: 4-12 weeks apart
Wash out period: 4-12 weeks (determined by waitlist time for second stage procedure - depends on allocation of date of surgery)

Intervention assignment: Sequential - each patient will receive a total of two stents (multilength first, then fixed length second)
Fixed length stent: 24cm for females, 26cm for males
All stents will be soft polyurethrane stents
The type of stent used is confirmed from operation reports (details of implant placed recorded) ie. audit of operation reports from Theatre Management System and medical records

Masking: None

Purpose: Treatment/device optimisation
Intervention code [1] 334560 0
Treatment: Devices
Description of the comparator or control
Comparator: Multilength stent
Control group
Active

Outcomes
Primary outcome [1] 345956 0
Patient-reported ureteric stent symptom burden
Timepoint [1] 345956 0
4 weeks after multilength stent and 1 week after fixed length stent
Secondary outcome [1] 463931 0
Lower urinary tract symptoms (LUTS)
Timepoint [1] 463931 0
4 weeks post multilength stent and 1 week post fixed length stent
Secondary outcome [2] 463932 0
Pain scores
Timepoint [2] 463932 0
4 weeks post multilength stent and 1 week post fixed length stent
Secondary outcome [3] 463933 0
Impact on quality of life
Timepoint [3] 463933 0
4 weeks post multilength stent and 1 week post fixed length stent

Eligibility
Key inclusion criteria
Age greater than or equal to 18 years
Undergoing ureteroscopy for urinary stone disease
Postoperative ureteric stent inserted
Able to provide informed consent
Completed postoperative symptom questionnaire
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Age under 18 years
Non-stone pathology
Resonance or other non-standard ureteric stent
Antegrade stent insertion
Incorrect stent placement
Failure to complete outcome assessment

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Stopped early
Data analysis
Data analysis is complete
Reason for early stopping/withdrawal
Participant recruitment difficulties
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA

Funding & Sponsors
Funding source category [1] 322263 0
Self funded/Unfunded
Name [1] 322263 0
Country [1] 322263 0
Primary sponsor type
Hospital
Name
Royal Perth Hospital
Address
Country
Australia
Secondary sponsor category [1] 325178 0
None
Name [1] 325178 0
Address [1] 325178 0
Country [1] 325178 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320783 0
Royal Perth Hospital Human Research Ethics Committee
Ethics committee address [1] 320783 0
Ethics committee country [1] 320783 0
Australia
Date submitted for ethics approval [1] 320783 0
26/05/2025
Approval date [1] 320783 0
16/06/2025
Ethics approval number [1] 320783 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151610 0
Dr Vivien Hsu
Address 151610 0
Royal Perth Hospital, 197 Wellington Street, Perth 6000 WA
Country 151610 0
Australia
Phone 151610 0
+61 892242244
Fax 151610 0
Email 151610 0
Contact person for public queries
Name 151611 0
Vivien Hsu
Address 151611 0
Royal Perth Hospital, 197 Wellington Street, Perth 6000 WA
Country 151611 0
Australia
Phone 151611 0
+61 892242244
Fax 151611 0
Email 151611 0
Contact person for scientific queries
Name 151612 0
Vivien Hsu
Address 151612 0
Royal Perth Hospital, 197 Wellington Street, Perth 6000 WA
Country 151612 0
Australia
Phone 151612 0
+61 892242244
Fax 151612 0
Email 151612 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.